Skip to product information
1 of 1
Sale

Imiquad Cream – Buy Online

Imiquad Cream – Buy Online

1000 in stock

SKU:MPH-IMIQUADCREAM-STANDARD-CREAM-1CREAM

Regular price $105.00 USD
Regular price $110.00 USD Sale price $105.00 USD
Pack Size
  • Free Shipping & Returns on this item
  • Delivery within 3-5 working days
View full details

What is Irinotel 100mg/5ml?

Irinotel 100mg/5ml is a prescription medication used in cancer treatment. It contains Irinotecan, a chemotherapy agent that belongs to a group of medicines known as topoisomerase I inhibitors. Healthcare professionals use this medication as part of treatment plans for certain types of cancers, particularly those affecting the colon and rectum.

Irinotel works by interfering with the growth and multiplication of cancer cells. Since cancer cells divide more rapidly than normal cells, the medication targets these fast-growing cells and helps slow or stop their spread. Treatment is administered under the supervision of qualified healthcare providers experienced in cancer care.

Active Ingredient

Generic Name: Irinotecan Hydrochloride

Strength: 100mg/5ml

Drug Class: Topoisomerase I Inhibitor

Dosage Form: Injection

Prescription Status: Prescription Only Medicine

How Irinotel 100mg/5ml Works

Cancer cells rely on specific enzymes to replicate their DNA and continue growing. Irinotecan blocks an enzyme called topoisomerase I, which plays an important role in DNA replication.

When this enzyme is inhibited, cancer cells cannot properly repair or reproduce their genetic material. As a result, cell division becomes disrupted, leading to cancer cell death and helping to slow disease progression. Because of this targeted action, Irinotel is often included in chemotherapy regimens designed to manage advanced or metastatic cancers.

Medical Uses of Irinotel 100mg/5ml

Healthcare providers may prescribe Irinotel as part of treatment protocols for various cancer-related conditions.

Colorectal Cancer

Irinotel is commonly used in the treatment of advanced colorectal cancer and may be administered alone or in combination with other anticancer medicines.

Metastatic Cancer Management

The medication may be recommended when cancer has spread beyond its original site and requires systemic treatment.

Combination Chemotherapy

Many treatment plans combine Irinotel with other chemotherapy agents to improve therapeutic outcomes and enhance treatment effectiveness.

Key Features of Irinotel 100mg/5ml

Established Chemotherapy Agent

Contains Irinotecan, a widely recognized medicine used in modern oncology treatment protocols.

Targeted Cellular Action

Works by disrupting DNA replication in rapidly dividing cancer cells.

Flexible Treatment Approach

May be administered as a single-agent therapy or as part of combination chemotherapy regimens.

Hospital-Based Administration

Given under professional medical supervision to ensure proper dosing and monitoring.

Clinically Utilized Worldwide

Used in cancer treatment centers and healthcare facilities across many countries.

Benefits of Irinotel 100mg/5ml

  • Helps slow the growth of cancer cells

  • Supports comprehensive cancer treatment plans

  • Can be combined with other chemotherapy medicines

  • Targets rapidly multiplying abnormal cells

  • Used in advanced colorectal cancer management

  • Administered under expert medical supervision

  • Plays an important role in modern oncology care

How Irinotel 100mg/5ml is Administered

Irinotel is administered by trained healthcare professionals through intravenous infusion. The dosage, treatment schedule, and duration depend on the type of cancer being treated and the patient's overall health status.

Patients should not attempt to self-administer this medication. Regular monitoring, blood tests, and follow-up appointments are typically required throughout treatment to evaluate response and manage potential side effects.

Dosage Considerations

Treatment decisions are individualized based on several factors, including:

  • Type and stage of cancer

  • Body surface area and weight

  • Overall health condition

  • Liver function status

  • Previous cancer treatments

  • Response to ongoing therapy

Only an oncologist or qualified healthcare professional should determine the appropriate treatment regimen.

Possible Side Effects

Like many chemotherapy medicines, Irinotel may cause side effects. The severity and frequency can vary among individuals.

Common Side Effects

  • Diarrhea

  • Nausea

  • Vomiting

  • Fatigue

  • Loss of appetite

  • Weakness

  • Hair thinning

  • Abdominal discomfort

Blood-Related Effects

Treatment may affect blood cell production, which can increase the risk of:

  • Infections

  • Anemia

  • Easy bruising

  • Bleeding tendencies

Serious Side Effects

Immediate medical attention may be required if symptoms such as severe diarrhea, high fever, difficulty breathing, severe dehydration, or signs of infection occur during treatment.

Precautions and Warnings

Before starting Irinotel therapy, patients should inform their healthcare provider about their complete medical history.

Special caution may be necessary for individuals with:

  • Liver disease

  • Existing infections

  • Intestinal disorders

  • Bone marrow suppression

  • Respiratory conditions

  • Previous chemotherapy complications

Regular medical monitoring is essential throughout treatment.

Drug Interactions

Certain medicines may alter the effectiveness of Irinotel or increase the risk of side effects.

Potential interactions may occur with:

  • Antifungal medications

  • Certain antibiotics

  • Seizure medications

  • Blood-thinning medicines

  • Immunosuppressive drugs

  • Herbal supplements

Patients should provide a complete list of medications, vitamins, and supplements before beginning treatment.

Storage Information

Healthcare facilities should store Irinotel according to manufacturer recommendations.

General storage guidelines include:

  • Keep in original packaging

  • Protect from excessive heat and light

  • Store according to labeled temperature requirements

  • Do not use beyond the expiration date

  • Keep out of reach of children

Who Should Not Use Irinotel 100mg/5ml?

This medication may not be suitable for:

  • Individuals with known hypersensitivity to Irinotecan

  • Patients with certain severe bone marrow disorders

  • Individuals with uncontrolled infections

  • Patients whose healthcare provider determines treatment risks outweigh benefits

A thorough medical evaluation is necessary before initiating therapy.

Important Patient Information

Irinotel 100mg/5ml is a specialized chemotherapy medicine intended for use under professional medical supervision. Treatment plans are highly individualized, and patients should follow all instructions provided by their oncology team. Regular monitoring, laboratory testing, and communication with healthcare providers are important components of safe and effective treatment management.